التداخل بين فوسابريبيتانت وفينوريلبين

Inhibitors of CYP3A4: May cause earlier onset and/or increased severity of adverse reactions ( 7.1 )

CYP3A Inhibitors Exercise caution in patients concurrently taking drugs known to inhibit CYP3A.

Concurrent administration of vinorelbine with a CYP3A inhibitor may cause an earlier onset and/or an increased severity of adverse reactions.

Etoposide, vinorelbine, paclitaxel, and docetaxel No dosage adjustment needed.